MB
Memorises Bio at Festival of Biologics 2026
Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website
Memorises Bio takes part in 3 sessions at Festival of Biologics 2026 in Basel. Its program spans antibody discovery and clinical development for cancer. Topics include finding new antibody and target pairs in tumors to build antibody-drug conjugates, and adaptive trial designs that speed up clinical development.
| Organization | Festival of Biologics 2026 Attendance |
|---|---|
MB Memorises Bio | |
Therapeutic antibody discovery company spun out of Memo Therapeutics, keeping its DROPZYLLA discovery platform. | Talk Tue Oct 13 16:50 Adaptive trial designs to expedite clinical development Ways to design clinical trials that adapt as data arrive to speed up development, with regulatory lessons and real company examples. Talk Wed Oct 14 11:30 Discovery of novel tumor derived antibody/target pairs for ADC drug development How antibody libraries built from tumors reveal new cancer targets, with early proof that antibody–drug conjugates against them can work. Talk Wed Oct 14 14:10 |
Instantly find 20 buyers from Memorises Bio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction